AzTrials
AzTrials

Social AnxietyNCT02756507

Transdiagnostic REBT Prevention Program for Adolescents

A study testing video-based transdiagnostic REBT and Wait list in people with Social Anxiety and Major Depression Mild, run by Babes-Bolyai University at 1 site in Romania.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Anxiety and depressive disorders are common in adolescents, however they are often unrecognized. Rational emotive behavioral therapy (REBT), a form of cognitive behavioral therapy (CBT) is efficient for children and adolescents. Read more about this study

Who is it for?
Ages 12 to 17 yearsHealthy volunteers can take part
What is being tested?
video-based transdiagnostic REBT and Wait list
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
381 participants
Where
1 siteRomania
Study dates
Jun 2016to Jun 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 17 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Preadolescents and adolescents will have ages between 12 and 17 years old;
  • Are attending middle school or high-school;
  • Adolescents have sufficient understanding of the Romanian language in order to complete assessments at all time points and to participate in the prevention program;
  • Their parents have sufficient understanding of the Romanian language in order to sign the informed consent;
  • Parents will sign the informed consent and adolescents will provide informed assent.

Who cannot join

  • Age below 14 or above 17 years;
  • No signed informed consent from parents;
  • Adolescents will score high on suicidal ideation according to (1 item on the Depression subscale from Beck Youth Inventories);
  • Not Romanian-speaking in order to understand the content of the prevention program and to complete the assessments.

Trial locations and contacts

1 site in 1 country.

Romania1 site
  • Babes-Bolyai University

    Cluj-Napoca, 400015

Other trials in Romania

About this study

Official title: The Efficacy of a Video-based Transdiagnostic REBT Universal Prevention Program Delivered in a School Context for Internalizing Problems in Adolescents

Anxiety and depressive disorders are common in adolescents, however they are often unrecognized. Rational emotive behavioral therapy (REBT), a form of cognitive behavioral therapy (CBT) is efficient for children and adolescents. School settings are appropriate environments to deliver such interventions for vulnerable youths. Given youth's access and predilection to use technology, a video-based prevention program was developed. The present study aims to investigate the efficacy of a transdiagnostic REBT prevention program for internalizing symptoms in adolescents, implemented in a school setting.

Classes from different Romanian public schools will be randomized in either intervention or wait list group.

Read the detailed description

The prevention program will be group-based, delivered in 6 sessions, over 3 weeks.

Each of the six modules aimed a different component: Psychoeducation, Relaxation, Relationship between cognitive distortions/irrational beliefs and emotions, Cognitive restructuring, Exposure/ behavioral activation and problem solving, Maintenance of gainings. Despite specific activities, for each session a video cartoon on that subject will be viewed and discussed. Homework would be given at every session.

REBT prevention programs delivered in school settings represent ecological modalities to target vulnerable groups. Technology components added to traditional programs may lead to greater motivation and satisfaction with treatment.

Adolescents will complete assessments at four time-points: T1 (baseline), T2 (post-intervention), T3 (3 months follow-up) and T4 (12 months follow-up).

Being tested
video-based transdiagnostic REBT, Wait list
Keywords
anxiety symptoms, depression symptoms, internalizing symptoms
Medical subject headings
Panic Disorder, Phobia, Specific, Generalized Anxiety Disorder, Anxiety Disorders, Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • video-based transdiagnostic REBTBehavioural

    The video-based transdiagnostic REBT consists of 6 sessions delivered in a group format.

  • Wait listBehavioural

    Delayed intervention

Study groups in NCT02756507
Study groupRoleWhat they receive
video-based transdiagnostic REBTExperimentalChildren and adolescents in the experimental group attend 6 modules of video-based transdiagnostic rational emotive behavioral therapy (REBT). Each of the six modules aimes a different component: Psychoeducation, Relaxation, Relationship between cognitive distortions/irrational beliefs and emotions, Cognitive restructuring, Exposure/ behavior activation and problem solving, Maintenance of gaining.
Receives: Behavioral: video-based transdiagnostic REBT
wait listSham comparatorThe wait-list is a delayed treatment condition.
Receives: Behavioral: Wait list

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The Multidimensional Anxiety Scale for Children (MASC; March, Parker, Sullivan, Stallings, & Conners, 1997)

    anxiety symptoms

    Measured: Change from baseline anxiety symptoms at 3 weeks post-intervention, 3 months follow up, 12 months follow-up

  2. Beck Depression Inventory for Youth subscale from the Beck Youth Inventories-Second edition for children and adolescents (Beck, 2005)

    depressive symptoms

    Measured: Change from baseline depressive symptoms at 3 weeks post-intervention, 3 months follow up, 12 months follow-up

Secondary outcomes (5)
  1. The Children's Automatic Thoughts Scale - Negative/Positive (CATS-N/P) (Hogendoorn et al., 2010)

    maladaptive cognitions

    Measured: Change from baseline maladaptive cognitions at 3 weeks post-intervention, 3 month follow up, 12 months follow-up

  2. The Strengths and Difficulties Questionnaire (SDQ) (Goodman, 1997)

    comorbid problems

    Measured: Change from baseline comorbid problems at 3 weeks post-intervention, 3 months follow up, 12 months follow-up

  3. The Questionnaire for Measuring Health-Related Quality of Life in Children and Adolescents, The Revised Version - adolescent version (Kiddo-KINDL) (Ravens-Sieberer et al., 2001)

    quality of life

    Measured: Change from baseline quality of life at 3 weeks post-intervention, 3 months follow up, 12 months follow-up

  4. The Credibility/ Expectancy Questionnaire (Devilly & Borkovec, 2000)

    Treatment expectancies

    Measured: pre-intervention

  5. The Client Satisfaction Scale (Vigerland et al., 2016)

    Satisfaction with the intervention

    Measured: post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Apr 2016 (estimated)
  2. Study startJun 2016
  3. Primary completionJun 2018
  4. Study completionJun 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
381 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02756507
Sponsor's protocol ID
PN-II-PT-PCCA-2011-3.1-1500
Status last verified
Feb 2023
First submitted
25 Apr 2016
Last updated
8 Feb 2023
Results posted
No
Data monitoring committee
Yes
Individual data sharing
Yes: Data will be shared upon reasonable request.

Publications

  • Pasarelu CR, Dobrean A. A video-based transdiagnostic REBT universal prevention program for internalizing problems in adolescents: study protocol of a cluster randomized controlled trial. BMC Psychiatry. 2018 Apr 13;18(1):101. doi: 10.1186/s12888-018-1684-0.

    PubMed 29653523

Questions about this trial

What is this clinical trial studying?

A study testing video-based transdiagnostic REBT and Wait list in people with Social Anxiety and Major Depression Mild, run by Babes-Bolyai University at 1 site in Romania.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Romania. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The Multidimensional Anxiety Scale for Children (MASC; March, Parker, Sullivan, Stallings, & Conners, 1997) (time frame: Change from baseline anxiety symptoms at 3 weeks post-intervention, 3 months follow up, 12 months follow-up). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02756507, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Feb 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in